Robert Berman
Director/Board Member bij SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II
Profiel
Robert Berman was the founder of Biohaven Pharmaceuticals, Inc., which was founded in 2013, where he held the title of Chief Medical Officer from 2013 to 2019.
Currently, he is an Independent Director at Social Capital Suvretta Holdings Corp.
II, where he started in 2022.
Dr. Berman received his undergraduate degree from Yale University and another undergraduate degree from Icahn School of Medicine at Mount Sinai in 1990.
Actieve functies van Robert Berman
| Bedrijven | Functie | Begin |
|---|---|---|
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Director/Board Member | 29-06-2022 |
Eerdere bekende functies van Robert Berman
| Bedrijven | Functie | Einde |
|---|---|---|
Biohaven Pharmaceuticals, Inc.
 Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Founder | 01-01-2019 |
Opleiding van Robert Berman
| Yale University | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Finance |
| Bedrijven in privébezit | 1 |
|---|---|
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Commercial Services |
